Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This is a 30‐month, Phase III, multicenter, randomized, double‐masked, sham‐injection controlled study to assess the efficacy and safety of multiple IVT injections of APL‐2 in subjects with GA secondary to AMD.
Epistemonikos ID: f9e1793c5b4a6040739a5f05d85d088c28cb3380
First added on: May 21, 2024